---
author: mike
pubDatetime: 2024-05-01 12:45:16.851000
modDatetime: 
title: Q124 MMM earnings
slug: q124-mmm-earnings
featured: false
ogImage: /assets/images/250_250.png
tags:
  - transcripts
  - earnings
  - conglomerates
description: Earnings summary for 3M
---
### Earnings Results
- Adjusted revenue for Q1 2024 was $7.7 billion.
- Achieved double-digit adjusted earnings growth with earnings of $2.39 per share, a 21% increase.
- Improved organic growth, with an adjusted organic growth rate of nearly 1% or up 2.4%, excluding certain initiatives.
- Operating margins increased to 22%, up 400 basis points.
- Safety and Industrial business posted sales of $2.7 billion, down 1.4% organically, with adjusted operating income of $664 million, up 18%.
- Transportation and Electronics business posted adjusted sales of $1.8 billion, up 6.7% organically, with adjusted operating income of $479 million, up 68%.
- Consumer business posted first quarter sales of $1.1 billion, with organic sales declining 3.9%, and operating income of $216 million, up 21%.
- Health Care business showed organic growth of 1% and operating margins of 17.5%.

### Future Guidance
- Full year 2024 earnings guidance on a continuing operations basis reflects Health Care as discontinued operations.
- Anticipates adjusted organic growth to be flat to up 2% or up 1% to 3% excluding certain impacts.
- Operating margins expected to improve by approximately 200 to 275 basis points year-on-year from an illustrative midpoint of 18.7% for 2023.
- Adjusted EPS forecasted in the range of $6.80 to $7.30 per share, indicating over 15% growth at the midpoint.
- Adjusted free cash flow conversion expected to remain in the range of 90% to 110%.
- Anticipates a 1% foreign currency headwind to sales.
- Plans for adjusted capital expenditures down 20% year-on-year mainly due to completion of water filtration investments.
- Restructuring charges expected to be $250 million to $300 million, heavily weighted to the first half of the year.

### Trends, Market Conditions, Sentiment
- Positive momentum gained throughout 2023 and into Q1 2024, indicating strong operational execution and spending discipline.
- Solventum Corporation's spin-off expected to provide tailored capital allocation and boost investment priorities.
- Market conditions showed mixed industrial demand, stable consumer electronics end markets, soft semiconductor market at the start, and muted consumer discretionary spending.
- Emphasis on exiting all PFAS manufacturing by the end of 2025.
- Legal settlements (public water suppliers and Combat Arms litigation) resolved, with significant anticipated payments but providing certainty and finality.
- Geographic strength in China and EMEA, driven by electronics and automotive, contrasts with U.S. flatness due to consumer retail softness.

### Notable Quotes
- "In the first quarter, we delivered strong results that were better than our expectations as we return to adjusted organic growth and achieve double-digit adjusted earnings growth." - Michael Roman, CEO
- "As independent companies, both 3M and Solventum are better able to tailor their capital allocation and investment priorities to win in their respective markets." - Michael Roman, CEO
- "This provides us the certainty and finality the settlement was intended to achieve." - Regarding the Combat Arms settlement.
- "...our teams have made tremendous progress on fundamentally improving how we work, which is driving better performance across the business." - Monish Patolawala, CFO
- "We delivered a strong start to the year... well positioned for long-term success and consistent value creation for our customers and shareholders." - Monish Patolawala, CFO
